- Home
- YMAB vs LSEA Comparison
YMAB vs LSEA Comparison
Compare YMAB & LSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- LSEA
- Stock Information
- Founded
- YMAB 2015
- LSEA 2013
- Country
- YMAB United States
- LSEA United States
- Employees
- YMAB N/A
- LSEA N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- LSEA Homebuilding
- Sector
- YMAB Health Care
- LSEA Consumer Discretionary
- Exchange
- YMAB Nasdaq
- LSEA Nasdaq
- Market Cap
- YMAB 270.5M
- LSEA 300.4M
- IPO Year
- YMAB 2018
- LSEA N/A
- Fundamental
- Price
- YMAB $4.43
- LSEA $6.42
- Analyst Decision
- YMAB Buy
- LSEA Buy
- Analyst Count
- YMAB 11
- LSEA 4
- Target Price
- YMAB $18.73
- LSEA $13.75
- AVG Volume (30 Days)
- YMAB 328.7K
- LSEA 378.4K
- Earning Date
- YMAB 03-04-2025
- LSEA 04-30-2025
- Dividend Yield
- YMAB N/A
- LSEA N/A
- EPS Growth
- YMAB N/A
- LSEA N/A
- EPS
- YMAB N/A
- LSEA 0.47
- Revenue
- YMAB $87,685,000.00
- LSEA $1,550,337,000.00
- Revenue This Year
- YMAB $20.07
- LSEA $4.04
- Revenue Next Year
- YMAB $8.76
- LSEA $5.27
- P/E Ratio
- YMAB N/A
- LSEA $13.52
- Revenue Growth
- YMAB 3.38
- LSEA 28.13
- 52 Week Low
- YMAB $4.25
- LSEA $6.18
- 52 Week High
- YMAB $17.78
- LSEA $14.72
- Technical
- Relative Strength Index (RSI)
- YMAB 34.59
- LSEA 36.79
- Support Level
- YMAB $4.65
- LSEA $6.79
- Resistance Level
- YMAB $5.25
- LSEA $7.18
- Average True Range (ATR)
- YMAB 0.30
- LSEA 0.33
- MACD
- YMAB 0.03
- LSEA -0.05
- Stochastic Oscillator
- YMAB 6.32
- LSEA 14.91
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About LSEA Landsea Homes Corporation
Landsea Homes Corp is a homebuilding company. It designs and builds homes and sustainable master-planned communities in some of the nation's desirable markets. The company's segments include Arizona, California, Florida, Metro New York, and Texas. It derives a majority of revenue from home sales in Florida.